How to Talk to Your Doctor About Sexual Health
Many people with active sexual health needs are not getting the testing and care they should — not because the care isn't available, but because the conversation with a doctor feels too awkward to have. This guide gives you the exact words to use, what to ask for, and what to do when standard healthcare isn't accessible or comfortable.
Why This Conversation Is Hard and Why It Matters
Most people who are sexually active with multiple partners, who use adult services, or who have other risk factors for sexually transmitted infections don't get tested as often as the evidence suggests they should. The reasons are multiple: the conversation with a primary care doctor feels awkward, there is fear of judgment or disclosure, people aren't sure what to ask for, or there is an assumption that absence of symptoms means absence of infection — which for many STIs is simply not true.
The epidemiology of STIs is an argument for more frequent testing by sexually active people, not less. Chlamydia, gonorrhea, syphilis, and HIV can all be entirely asymptomatic for extended periods. Someone who tests clean and continues engaging in sexual activity with new partners is not necessarily still clean three or six months later — and without testing, they don't know and can't make informed decisions about treatment or transmission prevention. The testing cadence that most public health guidelines recommend is more frequent than most general practice doctors proactively suggest, particularly for patients with higher-risk sexual activity patterns.
This guide is designed to make the healthcare conversation practical: what to say, what to ask for specifically, and how to access testing through alternative channels when your primary care relationship isn't the right venue.
What Your Doctor Is (and Isn't) Likely to Ask
Most primary care doctors do not proactively ask detailed sexual history questions at routine appointments. In some countries — the UK, the Netherlands, Australia — sexual health is more integrated into primary care, and doctors are more likely to take a sexual history routinely. In the US, Canada, and many other countries, sexual health is underprioritized at routine appointments, and specific sexual health needs require the patient to raise them.
This means the default is that your doctor does not know about your sexual activity patterns, your number of partners, your use of adult services, or your specific risk profile — and that routine blood work and physical examinations will not include STI screening unless you ask for it. The first practical implication is simple: you have to ask.
When you do ask, most doctors are significantly less judgmental than patients fear. Medical training increasingly emphasizes non-judgmental sexual health communication, and most practicing physicians have heard essentially everything. The awkwardness patients expect is often a product of anticipation rather than reality. When you say "I'd like to talk about STI screening," most doctors shift into clinical mode without editorializing about your personal life.
That said, not all doctors are equally skilled at this. Some physicians — particularly those in conservative practice environments or with strong personal values about sexual behavior — are less comfortable with frank sexual health conversations. If you encounter this, it is not your job to manage your doctor's discomfort. You have options, including specialist services, sexual health clinics, and online-accessed care, described later in this guide.
The Conversation: What to Actually Say
Having a specific script in mind makes the conversation easier. The level of disclosure you need depends on what you are asking for — you don't need to describe your sexual life in detail to get appropriate testing, but you need to convey enough for your doctor to order the right panel.
The Minimum Disclosure Opening
This is enough to trigger appropriate STI testing without requiring detail about your activities:
"I'd like to talk about sexual health at this appointment. I've been sexually active with more than one partner in the past year, and I'd like to make sure I'm up to date on STI screening. Can we go through what tests make sense given my situation?"
This statement conveys the key clinical fact — multiple partners — without specifying anything about the nature of those interactions. It also frames the conversation as proactive health management rather than a problem response, which tends to produce a more collaborative clinical interaction.
If You Use Adult Services
If you have used adult services, that is relevant clinical information that affects both the likelihood of certain infections and the recommended testing cadence. You do not have to use the phrase "escort" or "sex worker" — you can convey the relevant information in clinical language:
"I've had some sexual contact with partners I don't have an ongoing relationship with, including commercial sexual encounters. I know this puts me in a higher-risk category for STIs, and I'd like to make sure my testing reflects that."
Or, more directly if you're comfortable:
"I've used adult services on some of my travels. I understand this is relevant to my STI risk profile and I want to make sure I'm being tested appropriately."
Physicians are ethically bound to maintain confidentiality about what you disclose in a medical consultation. In most jurisdictions, the only exception is mandatory reporting of specific notifiable diseases — HIV and some other STIs — which typically involves reporting the case to public health authorities without identifying the sexual source. Disclosure to employers, insurance companies, or family members is not appropriate and not legally permitted. You have a right to ask your doctor directly about their confidentiality practices if you are uncertain.
If You're Traveling
For travelers who have had sexual contact abroad, destination matters clinically — STI prevalence varies significantly by region, and some infections are more common in specific areas. A brief description is helpful:
"I recently returned from [Southeast Asia / Eastern Europe / Latin America — whichever is accurate] and had sexual contact there. Given that I was in a region with different STI prevalence patterns, I want to make sure I'm being tested for the full range of relevant infections, including any that might be more specific to that region."
What Tests to Request and Why
The specific tests that constitute comprehensive STI screening depend on your practices, anatomy, and exposure history. The following is the standard comprehensive panel recommended for sexually active individuals with multiple partners — more specific variations are noted for specific situations.
Core Comprehensive Panel
- HIV (4th generation Ag/Ab combination test): The standard HIV test in most settings. This test can detect most HIV infections within 18-45 days of exposure. Specify that you want the 4th generation test, not the older antibody-only test, as it has a significantly shorter window period.
- Syphilis (RPR or VDRL with reflex to treponemal testing): A blood test. Early syphilis is highly treatable but can be asymptomatic. Rates of syphilis have increased significantly across Western countries over the past decade and should be part of any comprehensive panel.
- Gonorrhea and Chlamydia: Swab tests from any anatomical sites that have had sexual exposure. For insertive sex, urine or urethral swab. For oral exposure, throat swab. For anal exposure (receptive), rectal swab. Many doctors default to urine-only testing even for patients with oral and anal exposure — specifically requesting site-appropriate swabs matters because genital-only testing misses significant numbers of gonorrhea and chlamydia infections that are localized to throat or rectum.
- Hepatitis B surface antigen and antibody: Relevant to assess both current infection and vaccination-induced immunity. If you are not immune and not vaccinated, hepatitis B vaccination should be offered.
- Hepatitis C antibody: Relevant for patients with injection drug use history, but also increasingly documented in transmission through unprotected sex, particularly in MSM populations.
- Herpes (HSV-1 and HSV-2) serology: Blood tests for herpes antibodies. Note that herpes serology is not part of standard STI panels in most healthcare systems because of high background prevalence and the nuanced counseling required around results. You may need to specifically request it and discuss with your doctor whether it is appropriate for your situation. The test has limitations — particularly for HSV-2 in the first few months after exposure — that your doctor should explain.
Additional Tests for Specific Situations
- Trichomonas: Common STI, easily treatable, often asymptomatic. Often missed in standard panels. Worth requesting specifically if you are uncertain whether it is included.
- Mycoplasma genitalium: Increasingly recognized as a cause of urethritis and other STI-like syndromes. Testing is not yet standard in all settings but is available in most labs. Ask specifically if you have had symptoms that might be consistent with STI but have tested negative for the common infections.
- HPV: Routine HPV testing is recommended for cervical cancer screening in those with a cervix; there is no approved screening test for HPV in those without a cervix. HPV vaccination is recommended up to age 26 in most guidelines and can be offered to those without prior vaccination up to age 45 depending on jurisdiction. Confirm your vaccination status and discuss whether vaccination is appropriate.
- Mpox (monkeypox) exposure assessment: Since the 2022 global mpox outbreak, awareness of mpox symptoms and vaccination has become relevant for sexually active adults, particularly in higher-risk networks. If you have been to destinations or events with known mpox transmission and have had sexual contact, discuss this specifically with your doctor.
What to Say When Requesting a Comprehensive Panel
"I'd like a comprehensive STI panel. To make sure we're covering everything, can you include HIV (4th generation), syphilis, gonorrhea and chlamydia at all relevant sites including throat and rectal if appropriate, hepatitis B and C, and any other tests you'd recommend given my activity level? I want to be proactive rather than reactive about this."
How Frequently Should You Test?
Testing frequency recommendations vary by organization and depend on individual risk profiles. The following is synthesized from guidelines including those of the CDC, the British Association for Sexual Health and HIV (BASHH), and the European AIDS Clinical Society (EACS).
General Population Sexually Active Adults (Multiple Partners)
Annually at minimum; every 6 months if you have more than 5 partners per year or engage in higher-risk practices.
Higher-Risk Individuals (Including Adult Service Clients)
Every 3 months is the recommendation from most sexual health specialist guidelines. This cadence allows for early detection of infections that would otherwise be asymptomatic for extended periods, gives a window period that ensures most infections from recent exposures are detectable, and provides regular access to sexual health counseling that can adjust practice and protection. Many sexual health clinics have systems that allow regular patients to book a 3-month follow-up at the time of each visit, making this easier to maintain.
After High-Risk Exposure
If you have had a specific high-risk exposure — unprotected sex with a partner of unknown status, a condom failure, or any situation where you are concerned about a specific transmission event — seek testing promptly and discuss the exposure with a healthcare provider. Post-exposure prophylaxis (PEP) for HIV is available and effective but must be started within 72 hours of exposure. Earlier is better.
Discussing PrEP
Pre-exposure prophylaxis (PrEP) is a daily medication (or, in more recent options, an injection taken every two months) that reduces HIV transmission risk by more than 99% when taken consistently. PrEP is appropriate for anyone at ongoing elevated HIV risk, including adult service clients who have regular unprotected or partially protected contact with partners of unknown HIV status.
Bringing It Up
In some healthcare systems, your primary care doctor may be unfamiliar with PrEP or may not have prescribing experience with it. In others, it is available and routinely prescribed in primary care. Either way, the conversation starter is straightforward:
"I've read about PrEP for HIV prevention and I think I may be a good candidate given my sexual activity. Can we talk about whether it would be appropriate for me and how to access it?"
If your primary care doctor is not able to prescribe or discuss PrEP comfortably, sexual health clinics are generally better equipped and more experienced. In many countries, PrEP is now available through telehealth services, which can provide a more comfortable consultation context for some patients.
PrEP Requirements and Follow-Up
Before starting PrEP, you will need to confirm HIV-negative status (you cannot take PrEP if you have undiagnosed HIV). Kidney function testing (PrEP can affect kidney function) and hepatitis B status should be checked. Follow-up on PrEP typically involves testing every 3 months for HIV, kidney function, and STIs — which aligns with the recommended general testing cadence for higher-risk patients, making PrEP follow-up appointments an efficient vehicle for comprehensive sexual health monitoring.
PrEP Access by Country
PrEP availability varies by country. In the UK, PrEP has been available on the NHS since 2020 through sexual health clinics. In the US, it is covered by insurance without copay for those with coverage and available at reduced cost through the manufacturer's patient assistance programs for those without. In Australia, PrEP is available through the PBS (subsidized). In Canada, it is available through most provincial drug plans. In France, it is available through the healthcare system. Many other countries have expanded access since 2020. If your primary care provider is uncertain about PrEP access in your country, the PrEP Access Now project and similar organizations maintain updated country-specific information.
Anonymous and Alternative Testing Options
Primary care testing is not the only option, and for some people it is not the right option. Several alternatives offer varying degrees of anonymity, accessibility, and comprehensiveness.
Sexual Health Clinics (GUM Clinics in the UK)
Specialized sexual health clinics exist in most large cities globally and offer comprehensive STI testing, often without requiring registration with a primary care provider, and with confidentiality practices specifically designed for this context. In many countries, sexual health clinic services are free or low-cost through the public health system.
Sexual health clinic staff are specialists who conduct these conversations daily and are consistently more comfortable with frank sexual health discussions than many primary care providers. For patients who have experienced judgment or discomfort in primary care sexual health conversations, a specialist clinic is often a significantly better experience.
The practical limitation is availability — sexual health clinics can have long wait times in some areas, and geographic access is uneven. Same-day appointments may be available for patients with symptoms; routine screening may require scheduling in advance.
At-Home Testing Services
At-home STI testing services — mail-in sample collection kits with laboratory processing — have expanded significantly in availability and quality since 2020. Services like Superdrug Online Doctor (UK), LetsGetChecked (US, UK, Ireland), Nurx (US), and country-specific equivalents allow testing for comprehensive STI panels through self-collected samples (blood spot, urine, swabs) sent to accredited laboratories.
The main advantages are complete privacy (no in-person interaction required), convenience, and the ability to test on your own timeline. The limitations are that self-collected swabs from throat and rectum require comfort with self-collection, and positive results require follow-up treatment through a clinical provider — the at-home service identifies the problem but doesn't resolve it.
For people who find in-person healthcare conversations difficult, at-home testing provides an accessible pathway to knowing their status, with the expectation that they will then access treatment if needed.
Community Testing Programs
Many cities have community-based HIV and STI testing programs — often run by LGBTQ+ organizations, harm reduction programs, or public health departments — that offer rapid testing with minimal registration requirements. These programs are specifically designed to reach populations that traditional healthcare doesn't serve well and are accustomed to providing non-judgmental service to people with complex health needs.
Rapid HIV tests (result in 20 minutes) are often available at these venues. While rapid tests are less sensitive than laboratory-based 4th generation tests, they are accessible and free, and a negative rapid result combined with a negative follow-up lab test provides high confidence.
Telehealth Sexual Health Services
Telehealth platforms that specialize in sexual health have proliferated since 2020. In the US, services like Wisp, Nurx, and Plushcare offer sexual health consultations, STI testing referrals, and PrEP prescribing via video or messaging. In the UK, online sexual health services including NHS-linked portals allow testing kit requests and results consultations without in-person attendance. These services vary in what they can provide — some can only order tests and provide results counseling, not treat — but for the assessment and testing portion of sexual health care, they are fully capable and often significantly more comfortable for patients who find the in-person conversation difficult.
After a Positive Result
A positive STI result requires clinical treatment. The specific treatment depends on the infection, and all common STIs that are bacterial — gonorrhea, chlamydia, syphilis, trichomonas — are treatable and curable with antibiotics. HIV is not curable but is now a manageable chronic condition with modern antiretroviral therapy, and people on effective treatment have a normal life expectancy and are essentially non-transmissible (undetectable = untransmittable, U=U).
If you have been at-home testing, a positive result requires in-person follow-up. Most primary care doctors, sexual health clinics, and telehealth providers can manage treatment straightforwardly once you have a diagnosis. You do not need to re-explain your sexual history in detail — you can simply present the test result and request appropriate treatment.
Partner notification — informing sexual partners who may have been exposed — is an important public health practice and in some jurisdictions is legally required for certain infections. You can do this yourself or, in many cases, arrange for anonymous partner notification through your sexual health clinic or public health department, which contacts partners without revealing your identity.
Building a Regular Practice
The most effective approach to sexual health management is not reacting to concerns but building a regular practice. This means scheduling testing at the cadence appropriate for your risk profile, treating the testing appointment as a normal health maintenance activity, and establishing a clinical relationship — whether with a primary care provider, a sexual health clinic, or a telehealth service — where you don't have to re-explain your situation every time you seek care.
The conversation that feels hardest the first time becomes significantly easier with practice. Most people who have had one honest sexual health conversation with a healthcare provider — and experienced the non-judgmental, clinical response that most professionals give — find subsequent conversations much easier. The anticipatory anxiety is almost always worse than the actual conversation.
Your sexual health is your health. The same logic that applies to every other aspect of preventive healthcare — early detection, regular monitoring, proactive management — applies here. The fact that cultural stigma has historically made this category of health harder to manage is a real obstacle, but it is one that practical information, the right clinical resources, and a bit of courage to have the conversation can overcome.